Literature DB >> 29060753

11C-PIB PET image analysis for Alzheimer's diagnosis using weighted voting ensembles.

Janani Venugopalan, May D Wang.   

Abstract

Alzheimer's Disease (AD) is one of the leading causes of death and dementia worldwide. Early diagnosis confers many benefits, including improved care and access to effective treatment. However, it is still a medical challenge due to the lack of an efficient and inexpensive way to assess cognitive function [1]. Although research on data from Neuroimaging and Brain Initiative and the advancement in data analytics has greatly enhanced our understanding of the underlying disease process, there is still a lack of complete knowledge regarding the indicative biomarkers of Alzheimer's Disease. Recently, computer aided diagnosis of mild cognitive impairment and AD with functional brain images using machine learning methods has become popular. However, the prediction accuracy remains unoptimistic, with prediction accuracy ranging from 60% to 88% [2,3,6]. Among them, support vector machine is the most popular classifier. However, because of the relatively small sample size and the amount of noise in functional brain imaging data, a single classifier cannot achieve high classification performance. Instead of using a global classifier, in this work, we aim to improve AD prediction accuracy by combining three different classifiers using weighted and unweighted schemes. We rank image-derived features according to their importance to the classification performance and show that the top ranked features are localized in the brain areas which have been found to associate with the progression of AD. We test the proposed approach on 11C-PIB PET scans from The Alzheimer's Disease Neuroimaging Initiative (ADNI) database and demonstrated that the weighted ensemble models outperformed individual models of K-Nearest Neighbors, Random Forests, Neural Nets with overall cross validation accuracy of 86.1% ± 8.34%, specificity of 90.6% ± 12.9% and test accuracy of 80.9% and specificity 85.76% in classification of AD, mild cognitive impairment and healthy elder adults.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29060753      PMCID: PMC7324291          DOI: 10.1109/EMBC.2017.8037712

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  10 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Authors:  Liana G Apostolova; Kristy S Hwang; John P Andrawis; Amity E Green; Sona Babakchanian; Jonathan H Morra; Jeffrey L Cummings; Arthur W Toga; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Ronald C Petersen; Paul S Aisen; William J Jagust; Robert A Koeppe; Chester A Mathis; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

3.  Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy.

Authors:  Hanchuan Peng; Fuhui Long; Chris Ding
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2005-08       Impact factor: 6.226

4.  PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.

Authors:  J Koivunen; A Verkkoniemi; S Aalto; A Paetau; J-P Ahonen; M Viitanen; K Någren; J Rokka; M Haaparanta; H Kalimo; J O Rinne
Journal:  Brain       Date:  2008-06-25       Impact factor: 13.501

5.  Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles.

Authors:  Carlos Cabral; Margarida Silveira
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

6.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.

Authors:  Simon F Eskildsen; Pierrick Coupé; Vladimir S Fonov; Jens C Pruessner; D Louis Collins
Journal:  Neurobiol Aging       Date:  2014-08-28       Impact factor: 4.673

7.  Unbiased average age-appropriate atlases for pediatric studies.

Authors:  Vladimir Fonov; Alan C Evans; Kelly Botteron; C Robert Almli; Robert C McKinstry; D Louis Collins
Journal:  Neuroimage       Date:  2010-07-23       Impact factor: 6.556

Review 8.  PET imaging of amyloid in Alzheimer's disease.

Authors:  Agneta Nordberg
Journal:  Lancet Neurol       Date:  2004-09       Impact factor: 44.182

Review 9.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

10.  Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Authors:  Tammie L S Benzinger; Tyler Blazey; Clifford R Jack; Robert A Koeppe; Yi Su; Chengjie Xiong; Marcus E Raichle; Abraham Z Snyder; Beau M Ances; Randall J Bateman; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Paul S Aisen; Jon J Christensen; Lindsay Ercole; Russ C Hornbeck; Angela M Farrar; Patricia Aldea; Mateusz S Jasielec; Christopher J Owen; Xianyun Xie; Richard Mayeux; Adam Brickman; Eric McDade; William Klunk; Chester A Mathis; John Ringman; Paul M Thompson; Bernardino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Stephen Salloway; Stephen Correia; Peter R Schofield; Colin L Masters; Christopher Rowe; Victor L Villemagne; Ralph Martins; Sebastien Ourselin; Martin N Rossor; Nick C Fox; David M Cash; Michael W Weiner; David M Holtzman; Virginia D Buckles; Krista Moulder; John C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

  10 in total
  2 in total

Review 1.  Artificial intelligence for molecular neuroimaging.

Authors:  Amanda J Boyle; Vincent C Gaudet; Sandra E Black; Neil Vasdev; Pedro Rosa-Neto; Katherine A Zukotynski
Journal:  Ann Transl Med       Date:  2021-05

2.  Multimodal deep learning models for early detection of Alzheimer's disease stage.

Authors:  Janani Venugopalan; Li Tong; Hamid Reza Hassanzadeh; May D Wang
Journal:  Sci Rep       Date:  2021-02-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.